A pharmaceutically acceptable salt of mono-lysine salt of ((2R,3R)-3-(4-(4 cyanophenyl)thiazol-2-yl)-2-(2,4 difluorophenyl)-1-(1H-1,2,4-triazol-1 yl)butan-2-yloxy)methyl dihydrogen phosphate
PK140695AUndetermined Publication Date: 2010-04-26EISAI R&D MANAGEMENT CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200800564
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-04-26
Abstract
A pharmaceutically acceptable salt of mono-lysine salt of ((2R,3R)-3-(4-(4 cyanophenyl)thiazol-2-yl)-2-(2,4 difluorophenyl)-1-(1H-1,2,4-triazol-1 yl)butan-2-yloxy)methyl dihydrogen phosphate having the structure.
Need to check novelty before this filing date? Find Prior Art